Pancreatic Cancer Action

Pancreatic Cancer:  UK Survival Rates

UK Relative Survival to 1 & 5 years:

Now includes data from the Republic of Ireland

Relative Survival*

 

1-year (%)

5-year (%)

England1

Male

16.7

3.8

 

Female

18.5

3.4

Wales2

Male

14.3

2.8

 

Female

13.4

3.7

Scotland3

Male

15.3

3.6

 

Female

16.1

2.9

N.Ireland4

Male

11.3

< 10 patients

 

Female

10.8

< 10 patients

UK Average

Male

14.4

3.4

 

Female

14.7

3.3

 

Persons

14.5

3.4

Republic of IrelandMale14.66.0
 Female19.59.2
1 Office for National Statistics Statistical Bulletin: Cancer Survival in England patients diagnosed 2004-2008 followed up to 2009 Published 21 April 2011 http://www.statistics.gov.uk/pdfdir/can0411.pdf accessed 30/04/2011
2 Welsh Cancer Intelligence & Surveillance Unit (data extracted March 2010) Cancer Survival Trends in Wales: Period of diagnosis 2000-2004
3 ISD Scotland – patients diagnosed between 2003 and 2007 http://www.isdscotland.org/isd/1498.htmlaccessed April 2011
4 Northern Ireland Cancer Registry, Queens University, Belfast: 1-yr survival data period 2001-2003; 5-yr data period1997-2000http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/Pancreas/ accessed online April 2011

*Relative survival is an estimate of the observed survival divided by the expected probability of survival in the general population. This can be thought of as a measure of the net survival expectation after contracting cancer, or the probability of survival from cancer in the absence of other causes of death.

Comment:

The above survival rates are low and are a reflection of the fact that pancreatic cancer is often diagnosed at a late stage. Those patients who are diagnosed in time for surgery do considerably better and have a > 30% chance of surviving beyond five years after diagnosis*. This is why we at Pancreatic Cancer Action are campaigning for earlier diagnosis and developing educational and awareness programmes for the public and medical communities so more people can be diagnosed in time for surgery – currently the only potential for a cure.

*Ghaneh et al., (2008) Neoadjuvant and adjuvant strategies for pancreatic cancer EJSO 34 297-305

 

Pancreatic cancer has the lowest survival rates of all cancers and there has been no improvement over the past 40 years

male 5 year survival rate by cancer site up to 2008female 5 year survial rate by cancer site up to 2008

trends in 5 year survival rates per tumour site 1971 - 2008

There has been no improvement in the UK mortality rate for pancreatic cancer since 1955:

no improvement in UK survival rates for pancreatic cancer since 1955

The NHS Cancer Plan was introduced in England in 2001 to improve survival from cancers. This strategy has not improved the mortality from pancreatic cancer:

pancreatic cancer mortality rates 2001 - 2006

 

 

One-year survival rates for pancreatic cancer in the UK lag behind the European average according to EUROCARE Study (2009):

one year survival rates for pancreatic cancer in UK lag behind Europe

 

One-Year Survival (%) by Cancer Network in England

The NHS Cancer Plan (2000) established cancer networks as the organisational model that would bring about change and address the cancer plan agenda. Since then, other key pieces of national and regional guidance (such as the Cancer Reform Strategy 2007) have identified cancer networks as key players in the delivery of improvements to cancer services.

A cancer network is an organisational model, or a ‘way of working’. They bring together providers (organisations that provide services) and commissioners (organisations that plan, purchase and monitor services), as well as local authoritiesvoluntary and charity organisations and users of cancer services (patients and their carers) to work collaboratively as a system, to plan and deliver high quality cancer services for a given population.

There are currently 28 cancer networks in England. The graph below highlights the vast differences in one-year survival rates for pancreatic cancer between these networks. We don’t yet understand exactly why this is the case and more research needs to happen to identify the reasons for these inequalities.

differences in one year survival rates for pancreatic cancer between cancer networks in England